Erase PTSD Now pushes awareness of Stellate Ganglion Block for PTSD

Erase PTSD Now is urging patients, families and clinicians to look at the research on Stellate Ganglion Block, a treatment option for PTSD that remains unfamiliar to many people. The nonprofit says growing evidence and continued study should drive curiosity about trauma care, not assumptions.

Why it matters: - PTSD treatment is still not a one-size-fits-all process, and some people do not respond well to psychotherapy, medication or combinations of care. - Stellate Ganglion Block for PTSD is drawing more attention as researchers continue studying whether the procedure can ease symptoms tied to trauma. - Erase PTSD Now says broader awareness could help people with PTSD explore more treatment options, especially when standard approaches have not worked.

What happened: - Erase PTSD Now issued a public call for greater awareness of Stellate Ganglion Block, or SGB, for PTSD. - The organization said the procedure is unfamiliar to many people even though SGB has a long history in medicine, especially in pain management and sympathetic nervous system conditions. - Coleen LaCosta, executive director of Erase PTSD Now, urged people to read the research, question claims, listen to patients and consult qualified medical professionals.

The details: - SGB uses an injection of local anesthetic near the stellate ganglion, a cluster of sympathetic nerves in the neck involved in the body's stress response. - Researchers have studied whether temporarily blocking those nerves may reduce some PTSD symptoms. - The scientific literature on SGB and PTSD includes case reports, observational studies and randomized controlled research. - Additional research is ongoing on effectiveness, durability, technique and which patients may be most likely to benefit. - Erase PTSD Now says it maintains information for people who want to learn about SGB for PTSD. - The nonprofit said patient testimonials can help people understand why some seek the treatment, but those experiences are not a substitute for clinical trials.

Between the lines: - The nonprofit is challenging a common assumption that unfamiliar treatments are not legitimate. - The message reflects a broader shift in PTSD care, where researchers and patients are looking beyond traditional approaches. - The organization is also drawing a line between evidence and anecdote, emphasizing that scientific understanding advances through testing, replication and better data. - The release frames awareness as a starting point, not proof that SGB works.

What's next: - More research is expected to shape understanding of whether SGB helps PTSD, how durable any benefit may be and which patients might respond best. - Erase PTSD Now is encouraging patients, families, clinicians and the public to review the evidence and stay open to new findings. - People considering PTSD treatment are advised to speak with a qualified healthcare professional.

The bottom line: - Erase PTSD Now wants people to treat SGB as an evidence question, not a rumor test: learn first, decide later.